Experimental neurology · 2017
Progressive leukoencephalopathy impairs neurobehavioral development in sialin-deficient mice.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stroobants Stijn, Van Acker Nathalie G G, Verheijen Frans W, Goris Ilse, Daneels Guy F T, Schot Rachel, Verbeek Elly, Knaapen Michiel W M, De Bondt An, Göhlmann Hinrich W, Crauwels Marion L A, Mancini Grazia M S, Andries Luc J, Moechars Dieder W E, D'Hooge Rudi
Аннотация
Slc17a5-/- mice represent an animal model for the infantile form of sialic acid storage disease (SASD). We analyzed genetic and histological time-course expression of myelin and oligodendrocyte (OL) lineage markers in different parts of the CNS, and related this to postnatal neurobehavioral development in these mice. Sialin-deficient mice display a distinct spatiotemporal pattern of sialic acid storage, CNS hypomyelination and leukoencephalopathy. Whereas few genes are differentially expressed in the perinatal stage (p0), microarray analysis revealed increased differential gene expression in later postnatal stages (p10-p18). This included progressive upregulation of neuroinflammatory genes, as well as continuous down-regulation of genes that encode myelin constituents and typical OL lineage markers. Age-related histopathological analysis indicates that initial myelination occurs normally in hindbrain regions, but progression to more frontal areas is affected in Slc17a5-/- mice. This course of progressive leukoencephalopathy and CNS hypomyelination delays neurobehavioral development in sialin-deficient mice. Slc17a5-/- mice successfully achieve early neurobehavioral milestones, but exhibit progressive delay of later-stage sensory and motor milestones. The present findings may contribute to further understanding of the processes of CNS myelination as well as help to develop therapeutic strategies for SASD and other myelination disorders.
Предметные рубрики MeSH
Age FactorsAnimalsAnimals, NewbornBrainDevelopmental DisabilitiesDisease Models, AnimalGene Expression Regulation, DevelopmentalGlial Fibrillary Acidic ProteinIntermediate FilamentsLeukoencephalopathiesLysosomal-Associated Membrane Protein 1Mental DisordersMiceMice, Inbred C57BLMice, TransgenicOrganic Anion TransportersSialic Acid Storage DiseaseSymporters